News
Spero snaps up Innovent immunology drug in strategic pivot
Spero has licensed rights to an anti-CD40L antibody developed by China's Innovent, in a $1.1bn deal that signals a shift away from antimicrobial R&D.
News
AstraZeneca adds another Chinese asset, from Dizal
AstraZeneca has continued its pipeline-boosting deal spree in China with a $1.5bn licensing deal for Dizal Pharma's lung cancer therapy Zegfrovy.
News
First trial of Bundibugyo Ebola vaccine starts in UK
Oxford University has launched what it says is the world's first phase I trial of a vaccine specifically designed to protect against Bundibugyo Ebola.
News
Major trial launched to explore GLP-1 benefit in dementia
A $100m trial has been launched to see if lifestyle changes coupled with GLP-1 agonists or similar incretins can reduce the risk of dementia.
News
GSK to file Jemperli for rectal cancer after phase 3 readout
GSK's pivotal AZUR-1 trial of Jemperli monotherapy to delay or eliminate surgery in pre-operative rectal cancer has delivered a positive result.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
